ADO 6.52% 2.2¢ anteotech ltd

Covid-19 Test

  1. 4,308 Posts.
    lightbulb Created with Sketch. 12993
    have a new covid-19 page on our website, seems saliva testing has gone well and we are getting ready for more interest in our test...........

    OVERVIEW

    AnteoTech’s COVID-19 (SARS- CoV2) Antigen Rapid Test is a disposable immunochromatographic test for the detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from the respiratory mucosa or saliva sample. The test provides for the diagnosis of COVID-19. in the early stages of infection allowing for rapid diagnosis and decision support in the treatment and spread prevention of COVID-19.

    KEY ATTRIBUTES
    ACCURATE

    + Test detects COVID-19 in RT-PCR positive confirmed samples in the range of Ct 30 to Ct 35
    + LLOD estimated 20pg/mL

    APPLICATION

    WHAT SHOULD THE ANTEOTECH COVID-19 ANTIGEN RAPID TEST BE USED FOR?

    + Point of Care – To be used by trained clinicians in the clinical or point-of-care setting
    + For population screening for travel, events and densely populated areas
    + For businesses such as mine sites, cruise ships, office and remote operations

    REGISTER INTEREST

    OTHER TESTS

    • Clinical trials for multiplex test to occur in CY2021 Q1
    Sepsis Rapid Test.
    • Further development and commercialisation in 2021


    https://www.anteotech.com/test/
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
-0.002(6.52%)
Mkt cap ! $53.07M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $20.42K 928.5K

Buyers (Bids)

No. Vol. Price($)
7 1118907 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 7380 2
View Market Depth
Last trade - 15.45pm 05/09/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.